BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.92 Million USD | -11.88% |
| 2022 | 10.13 Million USD | 14.57% |
| 2021 | 8.84 Million USD | 22.81% |
| 2020 | 7.2 Million USD | 18.99% |
| 2019 | 6.05 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 8.26 Million USD | -16.85% |
| 2024 Q2 | 101.47 Million SEK | 5.72% |
| 2024 Q1 | 8.96 Million SEK | 6.12% |
| 2023 Q4 | 8.92 Million USD | 27.51% |
| 2023 FY | 8.92 Million USD | -11.88% |
| 2023 Q3 | 7 Million USD | -38.03% |
| 2023 Q2 | 11.29 Million USD | 27.21% |
| 2023 Q1 | 8.88 Million USD | -12.34% |
| 2022 Q2 | 8.7 Million USD | 0.0% |
| 2022 FY | 10.13 Million USD | 14.57% |
| 2022 Q4 | 10.13 Million USD | 58.74% |
| 2022 Q3 | 6.38 Million USD | -26.67% |
| 2021 FY | 8.84 Million USD | 22.81% |
| 2020 FY | 7.2 Million USD | 18.99% |
| 2019 FY | 6.05 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 50.26 Million USD | 82.238% |
| Skye Bioscience, Inc. | 14.07 Million USD | 36.558% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 84.872% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -1003.83% |
| Qrons Inc. | 1.48 Million USD | -499.693% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.9 Million USD | 43.867% |
| CSL Limited | 18.62 Billion USD | 99.952% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 87.681% |
| Arch Therapeutics, Inc. | 9.46 Million USD | 5.686% |
| Regen BioPharma, Inc. | 5.45 Million USD | -63.583% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 88.084% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -19874.295% |
| Rebus Holdings, Inc. | 5.24 Million USD | -70.311% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -32443.692% |
| Neon Bloom, Inc. | 1.22 Million USD | -628.072% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -4339.085% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 83.252% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | 6.829% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -2017.739% |
| SQZ Biotechnologies Company | 50.03 Million USD | 82.158% |
| Intellipharmaceutics International Inc. | 12 Million USD | 25.657% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -131.803% |
| Mesoblast Limited | 188.44 Million USD | 95.262% |
| Marizyme, Inc. | 26.67 Million USD | 66.532% |
| Genus plc | 485 Million USD | 98.159% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -52.803% |
| Pharming Group N.V. | 244.07 Million USD | 96.342% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -344.136% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -254.791% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -134.94% |
| ContraFect Corporation | 32.53 Million USD | 72.556% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -350.597% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -133.243% |
| IMV Inc. | 37.93 Million USD | 76.464% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | 24.201% |
| MultiCell Technologies, Inc. | 1617.67 USD | -551787.035% |
| ONE Bio Corp. | 27.49 Million USD | 67.531% |
| Accustem Sciences Inc. | 1.07 Million USD | -727.223% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 88.468% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -322.1% |
| Q BioMed Inc. | 8.13 Million USD | -9.772% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 89.235% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -73.487% |
| Biomind Labs Inc. | 1.49 Million USD | -495.732% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 92.48% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | 1.266% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 51.489% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -522.634% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -6182.917% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -55.377% |
| GB Sciences, Inc. | 5.41 Million USD | -64.792% |
| Alpha Cognition Inc. | 7.16 Million USD | -24.606% |
| HST Global, Inc. | 593.59 Thousand USD | -1404.012% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -609.003% |
| Halberd Corporation | 728.71 Thousand USD | -1125.124% |
| Enzolytics Inc. | 365.26 Million USD | 97.556% |
| Agentix Corp. | 2.51 Million USD | -255.607% |
| Resverlogix Corp. | 67.39 Million USD | 86.753% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -964.43% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 97.994% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -420.87% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 63.923% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | 24.997% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -143.583% |
| AVAX Technologies, Inc. | 3.99 Million USD | -123.542% |
| Zenith Capital Corp. | 27.56 Thousand USD | -32283.151% |
| Genscript Biotech Corporation | 1.32 Billion USD | 99.327% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -3640.86% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -139.073% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -1211.29% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -229.236% |
| Kadimastem Ltd | 3.5 Million USD | -154.723% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -13239.077% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -1821.181% |
| LadRx Corporation | 2.2 Million USD | -305.708% |
| Cell Source, Inc. | 15.8 Million USD | 43.52% |
| Regen BioPharma, Inc. | 5.45 Million USD | -63.583% |
| NovAccess Global Inc. | 7.86 Million USD | -13.574% |
| Affymax, Inc. | 8.87 Million USD | -0.639% |
| Itoco Inc. | 1.65 Million USD | -440.042% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -335.166% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -47.59% |
| Mobile Lads Corp. | 1.31 Million USD | -579.69% |
| CytoDyn Inc. | 127.89 Million USD | 93.019% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -21258.671% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -469.959% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | 19.172% |
| SYBLEU INC | 681.41 Thousand USD | -1210.176% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -46.31% |
| International Stem Cell Corporation | 5.27 Million USD | -69.182% |
| Bioxytran, Inc. | 3.24 Million USD | -174.741% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -1326.587% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -93.361% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 78.223% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 59.902% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -340.79% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -62.974% |
| Neutra Corp. | 973.52 Thousand USD | -817.046% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 69.231% |
| PureTech Health plc | 125.58 Million USD | 92.891% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -137.621% |
| IXICO plc | 1.9 Million USD | -369.807% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 56.512% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 91.359% |
| CSL Limited | 18.62 Billion USD | 99.952% |
| Cellectis S.A. | 249.36 Million USD | 96.42% |